Here the medical specialist shares his depth of knowledge about advances in Alzheimer’s disease diagnosis and treatment, the ...
“To more accurately stage disease and track progression over time ... and confirmatory testing for the amyloid pathology is ...
CNW/ - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Canada Inc. announced today that Health ...
This represents Alector's second failed neurodegenerative asset in a year, after an AbbVie-partnered asset missed in ...
An experimental drug from Alector Inc. failed to slow the decline of patients with frontotemporal dementia in a late-stage ...
The Canadian Press on MSN
Health Canada authorizes long-awaited drug to slow early-stage Alzheimer's disease
TORONTO — Health Canada has authorized a drug shown to slow the progression of Alzheimer's disease. Lecanemab is the first ...
Midland Reporter-Telegram on MSN
Craddick backs proposition to fund $3B dementia research institute
Rep. Tom Craddick and the Alzheimer’s Association urge voters to back Texas Proposition 14, creating DPRIT with $3B for ...
The U.S. Food and Drug Administration (FDA) has cleared another blood test that could help doctors identify whether a patient ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback